As a follow up to the article that appeared in Forbes magazine, Blood, the world’s leading haematology magazine, has published an article by Dr. Steve Treon. In the article, Dr. Treon explains the logic and process of ibrutinib’s possible effect on COVID-19. We have provided a .pdf of the article here.

Of extra interest to WMFC members is the reference to the transgenic mouse model which has been through two stages of research that the WMFC has funded and supported with Dr. Treon at the Dana Farber Cancer Institute over the last five or six years.